Pharmacielo Stock Performance
| PCLOF Stock | USD 0.06 0.01 20.00% |
Pharmacielo holds a performance score of 10 on a scale of zero to a hundred. The company holds a Beta of 1.47, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pharmacielo will likely underperform. Use Pharmacielo coefficient of variation, potential upside, day typical price, as well as the relationship between the sortino ratio and skewness , to analyze future returns on Pharmacielo.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmacielo are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Pharmacielo reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 8.9 M | |
| Total Cashflows From Investing Activities | -1.7 M |
Pharmacielo |
Pharmacielo Relative Risk vs. Return Landscape
If you would invest 3.40 in Pharmacielo on October 28, 2025 and sell it today you would earn a total of 2.60 from holding Pharmacielo or generate 76.47% return on investment over 90 days. Pharmacielo is currently producing 4.9657% returns and takes up 39.3086% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Pharmacielo, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Pharmacielo Target Price Odds to finish over Current Price
The tendency of Pharmacielo Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.06 | 90 days | 0.06 | about 14.8 |
Based on a normal probability distribution, the odds of Pharmacielo to move above the current price in 90 days from now is about 14.8 (This Pharmacielo probability density function shows the probability of Pharmacielo Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon the pink sheet has the beta coefficient of 1.47 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Pharmacielo will likely underperform. In addition to that Pharmacielo has an alpha of 5.356, implying that it can generate a 5.36 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Pharmacielo Price Density |
| Price |
Predictive Modules for Pharmacielo
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pharmacielo. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Pharmacielo Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pharmacielo is not an exception. The market had few large corrections towards the Pharmacielo's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pharmacielo, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pharmacielo within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 5.36 | |
β | Beta against Dow Jones | 1.47 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | 0.14 |
Pharmacielo Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pharmacielo for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pharmacielo can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pharmacielo is way too risky over 90 days horizon | |
| Pharmacielo has some characteristics of a very speculative penny stock | |
| Pharmacielo appears to be risky and price may revert if volatility continues | |
| Pharmacielo has high likelihood to experience some financial distress in the next 2 years | |
| Pharmacielo has accumulated 7.14 M in total debt with debt to equity ratio (D/E) of 0.71, which is about average as compared to similar companies. Pharmacielo has a current ratio of 0.79, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Pharmacielo until it has trouble settling it off, either with new capital or with free cash flow. So, Pharmacielo's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pharmacielo sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pharmacielo to invest in growth at high rates of return. When we think about Pharmacielo's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 1.94 M. Net Loss for the year was (26.63 M) with loss before overhead, payroll, taxes, and interest of (4.17 M). | |
| Pharmacielo has accumulated about 1.17 M in cash with (20.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Pharmacielo Fundamentals Growth
Pharmacielo Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Pharmacielo, and Pharmacielo fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pharmacielo Pink Sheet performance.
| Return On Equity | -0.98 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (3.22) % | |||
| Current Valuation | 38.68 M | |||
| Shares Outstanding | 151.41 M | |||
| Price To Book | 4.28 X | |||
| Price To Sales | 7.25 X | |||
| Revenue | 1.94 M | |||
| EBITDA | (24.75 M) | |||
| Cash And Equivalents | 1.17 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 7.14 M | |||
| Debt To Equity | 0.70 % | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (20.07 M) | |||
| Earnings Per Share | (0.12) X | |||
| Total Asset | 35.96 M | |||
About Pharmacielo Performance
By analyzing Pharmacielo's fundamental ratios, stakeholders can gain valuable insights into Pharmacielo's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pharmacielo has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pharmacielo has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. Pharmacielo is traded on OTC Exchange in the United States.Things to note about Pharmacielo performance evaluation
Checking the ongoing alerts about Pharmacielo for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Pharmacielo help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pharmacielo is way too risky over 90 days horizon | |
| Pharmacielo has some characteristics of a very speculative penny stock | |
| Pharmacielo appears to be risky and price may revert if volatility continues | |
| Pharmacielo has high likelihood to experience some financial distress in the next 2 years | |
| Pharmacielo has accumulated 7.14 M in total debt with debt to equity ratio (D/E) of 0.71, which is about average as compared to similar companies. Pharmacielo has a current ratio of 0.79, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Pharmacielo until it has trouble settling it off, either with new capital or with free cash flow. So, Pharmacielo's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pharmacielo sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pharmacielo to invest in growth at high rates of return. When we think about Pharmacielo's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 1.94 M. Net Loss for the year was (26.63 M) with loss before overhead, payroll, taxes, and interest of (4.17 M). | |
| Pharmacielo has accumulated about 1.17 M in cash with (20.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
- Analyzing Pharmacielo's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharmacielo's stock is overvalued or undervalued compared to its peers.
- Examining Pharmacielo's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pharmacielo's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharmacielo's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pharmacielo's pink sheet. These opinions can provide insight into Pharmacielo's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Pharmacielo Pink Sheet analysis
When running Pharmacielo's price analysis, check to measure Pharmacielo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacielo is operating at the current time. Most of Pharmacielo's value examination focuses on studying past and present price action to predict the probability of Pharmacielo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacielo's price. Additionally, you may evaluate how the addition of Pharmacielo to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |